At UPMC, we are doing everything we can to keep our communities safe from COVID-19. This page will provide the latest news and information about our response to COVID-19, including important UPMC announcements and updates on COVID-19 vaccines, treatments, and more.
UPMC clinical leaders provide an update on the impact of the Omicron variant in our communities. They also share more information about Evusheld — the first-ever monoclonal antibody authorized by the U.S. Food and Drug Administration (FDA) for the prevention of COVID-19 prior to an exposure — which we give to patients with immune-compromising conditions.
UPMC clinical leaders announce results of the first ever clinical study comparing methods to administer COVID-19 treatment during a surge in cases, discuss plans to analyze the effectiveness of vaccines and treatments against the Omicron COVID-19 variant, and share safety measures to take during the holiday season.
Tami Minnier, Chief Quality Officer, gives an update on how UPMC continues to manage the COVID-19 pandemic. Richard Beigi, MD, president, UPMC Magee-Womens Hospital, discusses the safety of COVID-19 vaccines for pregnant women, and Alejandro Hoberman, MD, president, UPMC Children’s Community Pediatrics, shares the safety data and plans for vaccinating children ages 5 to 11.
To learn more, visit our UPMC Newsroom.